We are live on ! Find out more
MIRM icon

Mirum Pharmaceuticals
MIRM

61 hedge funds and large institutions have $463M invested in Mirum Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 16

11% more capital invested

Capital invested by funds: $418M → $463M (+$45.3M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

4.37% less ownership

Funds ownership: 81.21% → 76.83% (-4.4%)

15% less funds holding

Funds holding: 72 → 61 (-11)

58% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 19

Holders
61
Holders Change
-11
Holders Change %
-15.28%
% of All Funds
1.07%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
8
Increased
22
Reduced
16
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Axa
Axa
France
+$5.04M
2
BlackRock
BlackRock
New York
+$3.94M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$2.16M
4
Two Sigma Investments
Two Sigma Investments
New York
+$1.55M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.15M

Top Sellers

1
ACM
AIGH Capital Management
Maryland
-$4.79M
2
Millennium Management
Millennium Management
New York
-$3.71M
3
CH
CVI Holdings
Delaware
-$2.48M
4
MIM
Monashee Investment Management
Massachusetts
-$2.18M
5
MS
Maven Securities
Jersey
-$1.82M
Name Holding Trade Value Shares
Change 		Change in
Stake
NMC
1
NEA Management Company
Maryland
$83M – – –
FM
2
Frazier Management
Washington
$70.7M – – –
DM
3
Deerfield Management
New York
$68.4M – – –
NHAS
4
Novo Holdings A/S
Denmark
$48.5M – – –
RVM
5
RiverVest Venture Management
Missouri
$38.1M – – –
RSCM
6
Rock Springs Capital Management
Maryland
$29.8M +$120K +6,275 +0.4%
BlackRock
7
BlackRock
New York
$15.1M +$3.94M +205,950 +37%
Vanguard Group
8
Vanguard Group
Pennsylvania
$14.7M +$2.16M +113,078 +18%
BBA
9
Baker Bros. Advisors
New York
$12.8M – – –
Axa
10
Axa
France
$11.3M +$5.04M +263,496 +86%
DCM
11
Driehaus Capital Management
Illinois
$10.2M -$537K -28,038 -5%
SI
12
Sofinnova Investments
California
$9.44M +$410K +21,427 +5%
SCM
13
Sio Capital Management
New York
$8.66M -$1.1M -57,605 -12%
BC
14
Boxer Capital
California
$6.28M – – –
BCM
15
Burrage Capital Management
Massachusetts
$4.08M +$847K +44,238 +27%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$3.42M +$1.15M +60,218 +54%
Ensign Peak Advisors
17
Ensign Peak Advisors
Utah
$2.5M – – –
Fidelity Investments
18
Fidelity Investments
Massachusetts
$2.27M -$860K -44,900 -28%
Wellington Management Group
19
Wellington Management Group
Massachusetts
$2.13M +$427K +22,300 +26%
Northern Trust
20
Northern Trust
Illinois
$1.92M -$26.8K -1,399 -1%
Two Sigma Investments
21
Two Sigma Investments
New York
$1.9M +$1.55M +81,020 +540%
State Street
22
State Street
Massachusetts
$1.8M -$84.2K -4,400 -5%
Millennium Management
23
Millennium Management
New York
$1.64M -$3.71M -194,033 -70%
Deutsche Bank
24
Deutsche Bank
Germany
$1.61M +$183K +9,545 +13%
Charles Schwab
25
Charles Schwab
California
$1.51M +$321K +16,764 +28%
1
2 3 4

MIRM Hedge Fund Activity: Q1 2021 in Review

61 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Mirum Pharmaceuticals (MIRM) for Q1 2021, worth a combined $463M — up 11% from $418M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of MIRM and 8 opened new positions — a net loss of 11 holders — while 16 trimmed existing stakes and 22 added.

The largest buyer was Axa, adding an estimated $5.04M. The largest seller was AIGH Capital Management, exiting entirely with an estimated $4.79M sold.

  • 61 institutional investors held Mirum Pharmaceuticals (MIRM) as of Q1 2021, down from 72 in Q4 2020.
  • Funds reported $463M of Mirum Pharmaceuticals stock for Q1 2021, up 11% quarter-over-quarter.
  • 8 funds opened new Mirum Pharmaceuticals positions in Q1 2021 and 19 closed out, a net change of -11 holders.
  • The largest Mirum Pharmaceuticals buyer in Q1 2021 was Axa, an estimated $5.04M added.
  • The largest Mirum Pharmaceuticals seller in Q1 2021 was AIGH Capital Management, an estimated $4.79M sold.

Based on aggregated 13F filings for Q1 2021.